angioimmunoblastic T-cell lymphoma
GPTKB entity
Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:affects |
lymphatic system
|
| gptkbp:associated_with |
immune system
|
| gptkbp:can_be_used_to |
gptkb:anemia
fatigue skin rash lymphadenopathy hepatomegaly splenomegaly |
| gptkbp:can_cause |
immune deficiency
|
| gptkbp:can_detect |
flow cytometry
immunohistochemistry |
| gptkbp:can_lead_to |
organ dysfunction
secondary malignancies |
| gptkbp:challenges |
treat
|
| gptkbp:characterized_by |
abnormal T-cells
|
| gptkbp:diagnosis |
variable
biopsy imaging tests other conditions |
| gptkbp:first_described_by |
1970s
|
| gptkbp:has_achieved |
infections
|
| https://www.w3.org/2000/01/rdf-schema#label |
angioimmunoblastic T-cell lymphoma
|
| gptkbp:is_associated_with |
targeted therapy
cytokine release syndrome paraneoplastic syndromes B symptoms |
| gptkbp:is_characterized_by |
angiogenesis
polyclonal hypergammaglobulinemia |
| gptkbp:is_common_in |
older adults
males |
| gptkbp:is_considered |
gptkb:aggressive_lymphoma
a rare disease a subtype of peripheral T-cell lymphoma |
| gptkbp:is_linked_to |
genetic mutations
immunosuppression |
| gptkbp:is_part_of |
hematologic malignancies
|
| gptkbp:is_related_to |
EBV infection
|
| gptkbp:may_be_treated_with |
clinical trials
|
| gptkbp:occurs_in |
other lymphomas
|
| gptkbp:requires |
radiation therapy
long-term follow-up |
| gptkbp:risk_factor |
age
autoimmune diseases HIV infection |
| gptkbp:scientific_classification |
NHL (Non-Hodgkin Lymphoma)
|
| gptkbp:symptoms |
weight loss
fever night sweats |
| gptkbp:treatment |
gptkb:immunotherapy
combination therapy chemotherapy stem cell transplant |
| gptkbp:type_of |
gptkb:Oncology
|
| gptkbp:bfsParent |
gptkb:Oncology
|
| gptkbp:bfsLayer |
4
|